viola poeschel: four or six cycles of chop in younger dlbcl patients?
Published 5 years ago • 1.1K plays • Length 4:31Download video MP4
Download video MP3
Similar videos
-
3:01
viola poeschel, md: 4 cycles of chop (instead of 6) is favorable for diffuse large b-cell lymphoma
-
2:03
dr. poeschel on 6 versus 4 cycles of r-chop in frontline dlbcl
-
2:18
diffuse large b-cell lymphoma: four cycles of chemotherapy as effective as six
-
4:51
viola poeschel: excellent outcome of young patients with favourable-prognosis dlbcl
-
4:19
is the combo of abbreviated chemo plus radiation therapy a viable option for dlbcl patients?
-
4:38
four cycles of chemotherapy as effective as six for diffuse large b-cell lymphoma
-
2:52
reducing chemotherapy in dlbcl: flyer results
-
2:13
phase ii trial of split-dose r-chop for older patients with dlbcl
-
1:40
fracture risk in older dlbcl patients after r-chop
-
4:40
reduced r-chop in favourable-prognosis dlbcl doesn't compromise outlook
-
1:44
remodl-b: bortezomib r-chop versus r-chop in patients with dlbcl
-
1:12
smart stop: moving away from r-chop in dlbcl
-
4:08
utilizing biology to improve on r-chop in dlbcl: targeting ubiquitous markers & mutational analysis
-
2:03
novel treatment approaches for early-stage dlbcl
-
26:29
what diffuse large b-cell lymphoma patients should receive therapy different from r-chop?
-
12:05
debate: should dlbcl patients be treated differently based on cell of origin? - yes
-
5:30
how the treatment landscape of dlbcl is changing: r-chop vs pola-r-chp
-
2:13
combination of mosunetuzumab with chop in dlbcl
-
2:35
association of interim pet2 response with outcomes in patients with dlbcl